Artivion

AORT · NYSE

$23.09+$0.81 (+3.64%)TodayMarket closed · Oct 20, 7:50 PM ET

Prev close $22.28

Latest news

NewsOct 12, 7:56 AM ET
Transcript: Artivion Q2 2026 Earnings Conference Call
Press releaseAug 6, 4:05 PM ETPRNewswire
Artivion Reports Second Quarter 2026 Financial Results
Press releaseJul 28, 4:10 PM ETPRNewswire
Artivion to Participate in Upcoming Investor Conferences
Press releaseJul 23, 4:10 PM ETPRNewswire
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results
NewsJun 29, 1:38 PM ETVandana Singh
Artivion Seeks To Tap $150 Million US Market Opportunity With FDA Approval
Press releaseJun 29, 7:00 AM ETPRNewswire
Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis
Press releaseJun 10, 4:10 PM ETPRNewswire
Artivion to Participate in the 2026 Truist Securities MedTech Conference
Press releaseMay 18, 7:05 AM ETBusiness Wire
Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System
Press releaseMay 18, 7:00 AM ETPRNewswire
Artivion Completes Acquisition of Endospan Ltd.
Press releaseMay 11, 11:30 AM ETPRNewswire
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Artivion, Inc.
NewsMay 8, 1:16 PM ETAvi Kapoor
Crude Oil Gains 1%; Fluor Shares Plunge After Q1 Results
NewsMay 8, 1:05 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsMay 8, 9:54 AM ETAvi Kapoor
Nasdaq Jumps 200 Points; US Adds 115,000 Jobs In April
NewsMay 8, 8:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsMay 7, 5:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsMay 7, 4:12 PM ET
Artivion Q1 Adj. EPS $0.08 Beats $0.05 Estimate, Sales $116.337M Beat $115.803M Estimate
Press releaseMay 7, 4:05 PM ETPRNewswire
Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan
Press releaseApr 23, 4:15 PM ETPRNewswire
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results
NewsApr 7, 10:00 AM ETAvi Kapoor
UnitedHealth, Alignment Healthcare, Humana And Other Big Stocks Moving Higher On Tuesday
Press releaseApr 7, 7:00 AM ETPRNewswire
Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System
Press releaseMar 3, 4:10 PM ETPRNewswire
Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Press releaseFeb 12, 4:05 PM ETPRNewswire
Artivion Reports Fourth Quarter and Full Year 2025 Financial Results
NewsFeb 2, 5:00 PM ET
The Analyst Verdict: Artivion In The Eyes Of 4 Experts
Press releaseFeb 2, 8:00 AM ETPRNewswire
Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting
Press releaseJan 29, 4:05 PM ETPRNewswire
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results
Press releaseNov 6, 4:05 PM ETPRNewswire
Artivion Reports Third Quarter 2025 Financial Results
Press releaseNov 6, 8:00 AM ETPRNewswire
Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial
NewsNov 6, 6:12 AM ET
Earnings Scheduled For November 6, 2025
Press releaseOct 29, 4:10 PM ETPRNewswire
Artivion to Participate in the Stifel 2025 Healthcare Conference
Press releaseOct 23, 4:10 PM ETPRNewswire
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results
Press releaseOct 13, 8:00 AM ETPRNewswire
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting
NewsSep 29, 9:10 AM ET
Beyond The Numbers: 7 Analysts Discuss Artivion Stock
Press releaseSep 5, 4:10 PM ETPRNewswire
Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
Press releaseAug 7, 4:05 PM ETPRNewswire
Artivion Reports Second Quarter 2025 Financial Results
NewsJun 17, 9:24 AM ETAvi Kapoor
This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Press releaseMay 5, 4:05 PM ETPRNewswire
Artivion Reports First Quarter 2025 Financial Results
Press releaseFeb 24, 4:05 PM ETPRNewswire
Artivion Reports Fourth Quarter and Full Year 2024 Financial Results
Press releaseJan 27, 8:00 AM ETPRNewswire
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting
Press releaseDec 9, 8:00 AM ETPRNewswire
Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Transcript: Artivion Q2 2026 Earnings Conference Call

Artivion Reports Second Quarter 2026 Financial Results

Artivion to Participate in Upcoming Investor Conferences

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results

Artivion Seeks To Tap $150 Million US Market Opportunity With FDA Approval

Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis

Artivion to Participate in the 2026 Truist Securities MedTech Conference

Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System

Artivion Completes Acquisition of Endospan Ltd.

Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Artivion, Inc.

Crude Oil Gains 1%; Fluor Shares Plunge After Q1 Results

12 Health Care Stocks Moving In Friday's Intraday Session

Nasdaq Jumps 200 Points; US Adds 115,000 Jobs In April

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

Artivion Q1 Adj. EPS $0.08 Beats $0.05 Estimate, Sales $116.337M Beat $115.803M Estimate

Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results

UnitedHealth, Alignment Healthcare, Humana And Other Big Stocks Moving Higher On Tuesday

Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System

Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Artivion Reports Fourth Quarter and Full Year 2025 Financial Results

The Analyst Verdict: Artivion In The Eyes Of 4 Experts

Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results

Artivion Reports Third Quarter 2025 Financial Results

Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial

Earnings Scheduled For November 6, 2025

Artivion to Participate in the Stifel 2025 Healthcare Conference

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

Beyond The Numbers: 7 Analysts Discuss Artivion Stock

Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Artivion Reports Second Quarter 2025 Financial Results

This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Artivion Reports First Quarter 2025 Financial Results

Artivion Reports Fourth Quarter and Full Year 2024 Financial Results

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting

Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis